Johnson & Johnson is recalling several over-the-counter medications, including Tylenol, Motrin and Benadryl, after consumers reported a moldy or musty smell.
It is another black mark for the drug company, which is already under heavy scrutiny by Congress and the Food and Drug Administration over four recent product recalls stemming from quality control problems.
The drugs were sold in the United States, Fiji, Guatemala, the Dominican Republic, Puerto Rico, Trinidad and Tobago and Jamaica, but the company said it did not know the total number of bottles involved. The list of medications includes Benadryl, Children’s Tylenol, Motrin IB, Tylenol Extra Strength and Tylenol Day and Night.
About 70 people noticed the odor, and became sick with symptoms like nausea, stomach pain, vomiting and diarrhea, Johnson & Johnson said. The company said it traced the odor to the same chemical on wooden shipping pallets that spurred the January 15 recall of 53 million bottles.
“This recall does raise questions surrounding why there wasn’t a more exhaustive recall initially and whether there is an adequate system in place that can readily identify every product that has been affected,” Kurt Bardella, spokesman for Rep. Darrell Issa (R-Ca.) told Reuters.


